NCT ID | NCT00576654 |
Title | Irinotecan Hydrochloride and Veliparib in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | yes |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult |